4.7 Article

Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Hematology

Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19

Henry Ng et al.

Summary: Elevated levels of NET markers in patients with moderate to severe COVID-19 were found to be associated with disease severity, respiratory support requirement, and short-term mortality. These markers declined to healthy individual levels four months post-infection. The study suggests a potential role of NETs in COVID-19 disease progression and as targets for novel therapeutic interventions.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)

Article Hematology

Vascular neutrophilic inflammation and immunothrombosis distinguish severe COVID-19 from influenza pneumonia

Leo Nicolai et al.

Summary: Our study reveals that vascular neutrophil recruitment, NETosis, and subsequent immunothrombosis are typical features of severe COVID-19, but less prominent in influenza pneumonia when comparing histopathological specimens of SARS-CoV-2 with influenza-affected lungs. Activated neutrophils were typically found in physical association with monocytes.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Article Hematology

COVID-19 and thrombosis: a continuing story

The Lancet Haematology

Lancet Haematology (2021)

Article Medicine, General & Internal

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

Patrick R. Lawler et al.

Summary: This study showed that therapeutic-dose anticoagulation with heparin in non-critically ill patients with Covid-19 increased the likelihood of survival to hospital discharge and reduced the need for cardiovascular or respiratory organ support compared to usual-care thromboprophylaxis.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

Ewan C. Goligher et al.

Summary: In critically ill patients with Covid-19, initial therapeutic-dose anticoagulation did not result in improved survival rates or fewer days requiring cardiovascular or respiratory organ support compared to usual-care pharmacologic thromboprophylaxis.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Infectious Diseases

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Victor M. Corman et al.

EUROSURVEILLANCE (2020)

Article Medicine, General & Internal

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19

Dominic Wichmann et al.

ANNALS OF INTERNAL MEDICINE (2020)

Letter Cardiac & Cardiovascular Systems

Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19

Ishan Paranjpe et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Review Cardiac & Cardiovascular Systems

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow

Behnood Bikdeli et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Article Hematology

D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19

Litao Zhang et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Letter Cell Biology

Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro

Paul S. Kwon et al.

CELL DISCOVERY (2020)

Article Cardiac & Cardiovascular Systems

Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19

Girish N. Nadkarni et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Letter Cardiac & Cardiovascular Systems

Differentiating biochemical from clinical heparin resistance in COVID-19

Ton Lisman et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)

Article Immunology

Increased Plasma Heparanase Activity in COVID-19 Patients

Baranca Buijsers et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Hematology

Routine haematological parameters in COVID-19 prognosis

David Pereyra et al.

Lancet Haematology (2020)

Review Medicine, General & Internal

Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients

Baranca Buijsers et al.

EBIOMEDICINE (2020)

Review Hematology

COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation

Wolfgang Miesbach et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2020)

Article Medicine, General & Internal

Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls

Jonathan A. C. Sterne et al.

BMJ-BRITISH MEDICAL JOURNAL (2009)